|
Woodstock, GA, October 17, 2015 – Tissue Regeneration Technologies, LLC (TRT) today announced the release of a groundbreaking article in the esteemed Journal of the American Heart Association (JAHA). The article concludes that shock wave therapy (SWT) can protect the body from paralysis that results from a lack of blood flow to the spinal cord following aortic surgery. Background
A rare but unfortunate complication following aortic surgery is a condition known as spinal cord ischemia, or in other words, a lack of blood flow to the spinal cord. This condition, which occurs in 15% of high-risk patients, results in the death of neurons within the spine. Consequently, patients begin to experience nearly irreversible symptoms of paraplegia immediately after the onset of spinal cord ischemia. The released article from the JAHA supports that shock wave therapy can reduce the risk of spinal cord ischemia immediately before, during, or even shortly after aortic surgery and counteract the symptoms of the condition after the onset of paraplegia. |
Specializing in sales of medical devices using our patented acoustic wave technology to profoundly accelerate healing and recoveries for the human body.
|
|
TRT is FDA cleared for the activation of connective tissue, and FDA Registered for pain reduction and improved blood supply
Additional FDA filings are in process
Additional FDA filings are in process
© Copyright Tissue Regeneration Technologies - 2018 | All Rights Reserved